Phase I/II study of EUS-HGS(EUS-guided hepaticogastrostomy) for malignant biliary tract obstruction

Phase I/II study of EUS-HGS(EUS-guided hepaticogastrostomy) for malignant biliary tract obstruction - Phase I/II of EUS-HGS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006785

Enrollment

Registered

2011-11-28

Start date

2011-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant biliary obstruction

Interventions

biliary obstruction

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Biliary drainage required for distal biliary obstruction caused by unresectable malignant tumor. 12. No tumor extension into the duodenal bulb or peri-bulbar tissues. 3. Maintained major organ function marrow, heart, liver, lungs, and kidneys. Absence of heart failure, platelet counts 4. Performance status (Eastern Cooperative Oncology Group): 0, 1, 2, or 3. 5.Predicted survival within 1 month. 6.Informed consent provided by the patient.

Exclusion criteria

Exclusion criteria: 1.Malignant obstruction of the gastrointestinal tract. 2.Block of the upstream bile duct on the hepatic side. 3.Pregnancy. 4.History of local radiotherapy or planned radiotherapy treatment of the tumor.

Design outcomes

Primary

Measure	Time frame
safety	—

Countries

Japan

Contacts

Public Contactkazuo hara

Aichi Cancer Center Gastroenterology

khara@aichi-cc.jp052-762-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026